Research network ScienceOpen has announced a partnership with the University of Huddersfield Press, a primarily open access publisher of high quality research, to promote the British Journal of Pharmacy - a new featured collection of scientific articles in pharmaceutical sciences.
British Journal of Pharmacy is an online, peer-reviewed, open access journal with no article processing charges (APCs). This publication is a product of University of Huddersfield Press' mission to improve access to scholarly work for the benefit of all by publishing innovative research as open access. The journal publishes research on the latest developments in pharmacy in the form of scholarly papers and critical reviews. Submissions can be accepted from a wide range of pharmaceutical sciences including, among others: pharmacy, molecular pharmacy, drug delivery and targeting, pharmacoeconomics, pharmacokinetics and therapeutics, pharmaceutical and medicinal chemistry, pharmacovigilance, and innovations in teaching pharmacy.
The new featured collection British Journal of Pharmacy brings together articles from the diversity of topics relevant to the field of pharmacy. 'Medical Pharmacology and Therapeutics' by Derek G. Waller and Anthony P. Sampson provides a deeper understanding of the principles of drug usage by explaining the basic science behind the clinical application of pharmacological agents. The critical review 'Going Natural: Using polymers from nature for gastroresistant applications' by Joao A.C. Barbosa, Barbara R Conway, and Hamid A. Merchant examines natural substances employed in producing gastroresistant products, their shortcomings and potential industrial applications, therein identifying the gaps in the current knowledge to encourage future research. Similarly, 'Systematic Review of Medicine-Related Problems in Adult Patients with Atrial Fibrillation on Direct Oral Anticoagulants' by Huda Alewairdhi, Nkiruka Umaru, and Zoe Aslanpour exemplifies the 'value of systematic review of medications to inform clinical practice' by identifying the inconclusiveness on major safety end points, including major bleeding, in English language literature on medicine-related problems of direct oral anticoagulants DOACs in the treatment of adults with atrial fibrillation.
Contextualising pharmacy in Britain as a research field contingent upon global political conditions, the journal features two papers by key opinion leaders about the implications of Brexit on the world of pharmacy. 'Brexit - What are the potential consequences for pharma patents and SPCs?' by Jamie Fraser and James Stone addresses the uncertain future of patents and SPCs if the UK fails to reach an agreement with the EU. In 'Breaking up the band: European regulatory cooperation in a post-Brexit world', Virginia Acha argues that-given all the implications of Brexit-the best decision is to maintain cooperation between the regulatory agencies Medicines & Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) under new structures.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
